CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma
CHEST · 2024
DOI: 10.1016/j.chest.2024.02.026 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift CHEST, 2024. Verfasst von Cendrine Godet und 28 weiteren Autor:innen. Beteiligte Einrichtung: Service de Pneumologie B et Transplantation pulmonaire, Université Paris Cité, Assistance Publique - Hôpitaux de Paris, Hôpital Bichat, Paris, France…. Hauptthemen laut MEDLINE: Aspergillosis, Allergic Bronchopulmonary, Tomography, X-Ray Computed, Asthma, Itraconazole. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Government of France Ministry of Health and Prevention.
Abstract (Originalsprache)
BACKGROUND: One of the major challenges in managing allergic bronchopulmonary aspergillosis remains consistent and reproducible assessment of response to treatment. RESEARCH QUESTION: What are the most relevant changes in CT scan parameters over time for assessing response to treatment? STUDY DESIGN AND METHODS: In this ancillary study of a randomized clinical trial (NebuLamB), patients with asthma with available CT scan and without exacerbation during a 4-month allergic bronchopulmonary aspergillosis exacerbation treatment period (corticosteroids and itraconazole) were included. Changed CT scan parameters were assessed by systematic analyses of CT scan findings at initiation and end of treatment. CT scans were assessed by two radiologists anonymized to the clinical data. Radiologic parameters were determined by selecting those showing significant changes over time. Improvement of at least one, without worsening of the others, defined the radiologic response. Agreement between radiologic changes and clinical and immunologic responses was likewise investigated. RESULTS: Among the 139 originally randomized patients, 132 were included. We identified five CT scan parameters showing significant changes at end of treatment: mucoid impaction extent, mucoid impaction density, centrilobular micronodules, consolidation/ground-glass opacities, and bronchial wall thickening (P < .05). These changes were only weakly associated with one another, except for mucoid impaction extent and density. No agreement was observed between clinical, immunologic, and radiologic responses, assessed as an overall response, or considering each of the parameters (Cohen κ, -0.01 to 0.24). INTERPRETATION: Changes in extent and density of mucoid impaction, centrilobular micronodules, consolidation/ground-glass opacities, and thickening of the bronchial walls were found to be the most relevant CT scan parameters to assess radiologic response to treatment. A clinical, immunologic, and radiologic multidimensional approach should be adopted to assess outcomes, probably with a composite definition of response to treatment. TRIAL REGISTRATION: ClinicalTrials.gov; No.: NCT02273661; URL: www. CLINICALTRIALS: gov).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service de Pneumologie B et Transplantation pulmonaire, Université Paris Cité, Assistance Publique - Hôpitaux de Paris, Hôpital Bichat, Paris, France. Electronic address: cendrine.godet@aphp.fr.
- Service de Radiologie, Hôpital Foch, Suresnes, France.
- Université Brest, INSERM U1304-GETBO, CHU Brest, Département de Médecine Interne et Pneumologie, CIC INSERM 1412, CHU Brest, FCRIN INNOVTE, France; Département de Médecine Interne et Pneumologie, CHU Brest, France.
- Université Bordeaux, INSERM, CRCTB, U 1045, F-33000 Bordeaux, France.
- Médecine Intensive Réanimation, CHU Poitiers, Poitiers, France; Université Poitiers, INSERM, CIC 1402, IS-ALIVE, CHU Poitiers, Poitiers, France.
- Université François Rabelais, Tours, INSERM 1100, Tours, France; Service de pneumologie et explorations fonctionnelles respiratoires, CHRU de Tours, Tours, France.
Förderung
- Government of France Ministry of Health and Prevention
Zitieren
APA
Godet, C., Brun, A. L., Couturaud, F., Laurent, F., Frat, J. P., Marchand-Adam, S., Gagnadoux, F., Blanchard, E., Taillé, C., Philippe, B., Hirschi, S., Andréjak, C., Bourdin, A., Chenivesse, C., Dominique, S., Mangiapan, G., Murris-Espin, M., Rivière, F., Garcia, G., …, & NebuLamB Study Group and GREPI Network (2024). CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma. CHEST. https://doi.org/10.1016/j.chest.2024.02.026
Vancouver
Godet C, Brun AL, Couturaud F, Laurent F, Frat JP, Marchand-Adam S, et al. CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma. CHEST. 2024. doi:10.1016/j.chest.2024.02.026
BibTeX
@article{Godet2024,
author = {Godet, Cendrine and Brun, Anne-Laure and Couturaud, Francis and Laurent, François and Frat, Jean-Pierre and Marchand-Adam, Sylvain and Gagnadoux, Frédéric and Blanchard, Elodie and Taillé, Camille and Philippe, Bruno and Hirschi, Sandrine and Andréjak, Claire and Bourdin, Arnaud and Chenivesse, Cécile and Dominique, Stéphane and Mangiapan, Gilles and Murris-Espin, Marlène and Rivière, Frédéric and Garcia, Gilles and Blanc, François-Xavier and Goupil, François and Bergeron, Anne and Flament, Thomas and Priou, Pascaline and Mal, Hervé and de Keizer, Joe and Ragot, Stéphanie and Cadranel, Jacques and NebuLamB Study Group and GREPI Network, NebuLamB Study Group and GREPI Network},
title = {CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma},
journal = {CHEST},
year = {2024},
doi = {10.1016/j.chest.2024.02.026}
}
EUVIMED